Silverback Therapeutics to Present at Upcoming Investor Conferences

Rhea-AI Summary

Silverback Therapeutics, Inc. (Nasdaq: SBTX) has announced that CEO Laura Shawver, Ph.D., will present at several upcoming virtual investor conferences. Key events include the Goldman Sachs West Coast Biotech Bus Tour on February 23, 2021, the SVB Leerink 10th Annual Global Healthcare Conference on February 24, 2021, the Cowen 41st Annual Healthcare Conference on March 3, 2021, and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021. Webcasts and replays of selected presentations will be available on Silverback's website for 30 days.

Silverback Therapeutics, Inc. (Nasdaq: SBTX) (“Silverback”), a clinical-stage biopharmaceutical company leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases, today announced that Laura Shawver, Ph.D., Silverback’s chief executive officer, will present at the following upcoming investor conferences:

• Event: Goldman Sachs West Coast Biotech Bus Tour
  Location: Virtual
  Date: Tuesday, February 23, 2021
  Time: 2:00 PM ET / 11:00 AM PT
  
  
• Event: SVB Leerink 10^th Annual Global Healthcare Conference
  Location: Virtual
  Date: Wednesday, February 24, 2021
  Time: 4:20 PM ET / 1:20 PM PT
  
  
• Event: Cowen 41^st Annual Healthcare Conference
  Location: Virtual
  Date: Wednesday, March 3, 2021
  Time: 3:20 PM ET / 12:20 PM PT
  
  
• Event: H.C. Wainwright Global Life Sciences Conference
  Location: Virtual
  Date: Tuesday, March 9, 2021
  Time: 7:00 AM ET / 4:00 AM PT

The webcast and archived replay of the SVB Leerink, Cowen, and H.C. Wainwright presentations will be available on the Silverback website, www.silverbacktx.com, for 30 days.

About Silverback Therapeutics

Silverback Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on leveraging its proprietary ImmunoTAC technology platform to develop systemically delivered and tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. Silverback’s platform enables the strategic pairing of proprietary payloads that modulate key disease modifying pathways with monoclonal antibodies directed at specific disease sites. Initially, Silverback is creating a new class of targeted immuno-oncology agents that direct a TLR8 agonist myeloid cell activator to the tumor microenvironment in solid tumors to promote cancer cell killing. Silverback Therapeutics is located in Seattle, Washington. To learn more, visit www.silverbacktx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210216005502/en/

FAQ

What events is Silverback Therapeutics presenting at in February and March 2021?

Silverback Therapeutics will present at the Goldman Sachs Biotech Bus Tour on February 23, the SVB Leerink 10th Annual Global Healthcare Conference on February 24, the Cowen 41st Annual Healthcare Conference on March 3, and the H.C. Wainwright Global Life Sciences Conference on March 9, 2021.

Where can I access the webcasts of Silverback Therapeutics' presentations?

Webcasts and archived replays of the presentations will be available on Silverback Therapeutics' website for 30 days following the events.

What is Silverback Therapeutics focused on developing?

Silverback Therapeutics is focused on developing tissue-targeted therapeutics using its ImmunoTAC technology platform for treating cancer, chronic viral infections, and other serious diseases.

When will Laura Shawver present at the SVB Leerink Global Healthcare Conference?

Laura Shawver will present at the SVB Leerink 10th Annual Global Healthcare Conference on February 24, 2021, at 4:20 PM ET.

What is the Nasdaq stock symbol for Silverback Therapeutics?

The Nasdaq stock symbol for Silverback Therapeutics is SBTX.